Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD, Scheri R, Roman SA, Sosa JA (2014) Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg 260:601–605
PubMedCrossRefAttard A, Paladino NC, Lo Monte AI, Falco N, Melfa G, Rotolo G, Rizzuto S, Gulotta E, Salamone G, Bonventre S, Scerrino G, Cocorullo G (2019) Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review. Surg 18(Suppl 1):112
Barbesino G, Goldfarb M, Parangi S, Yang J, Ross DS, Daniels GH (2012) Thyroid lobe ablation with radioactive iodine as an alternative to completion thyroidectomy after hemithyroidectomy in patients with follicular thyroid carcinoma: longterm follow up. Thyroid 22:369–376
PubMedPubMedCentralCrossRefBarney BM, Hitchcock YJ, Sharma P, Shrieve DC, Tward JD (2011) Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck 33:645–649
PubMedCrossRefBilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375–384
PubMedPubMedCentralCrossRefBongiovanni M, Faquin WC, Giovanella L, Durante C, Kopp P, Trimboli P (2019) Impact of non-invasive follicular thyroid neoplasms with papillary-like features (NIFTP) on risk of malignancy in patients undergoing lobectomy/thyroidectomy for suspected malignancy or malignant fine-needle aspiration cytology findings: a systematic review and meta-analysis. Eur J Endocrinol 181:389–396
PubMedPubMedCentralCrossRefBonnet S, Leboulleux S, Baudin E et al (2009) Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94:1162–1167
PubMedCrossRefBrauckhoff M, Meinicke A, Bilkenroth U et al (2006) Long-term results and functional outcome after cervical evisceration in patients with thyroid cancer. Surgery 140:953–955
PubMedCrossRefBrauckhoff M, Dralle H (2009) Zervikoviszerale Resektionen beim organüberschreitenden Schilddrüsenkarzinom. Chirurg 80:88–98
PubMedCrossRefBrauckhoff M, Machens A, Nguyen Thanh P et al (2010) Impact of extent of resection for thyroid cancer invading the aerodigestive tract on surgical morbidity, local recurrence and cancer-specific survival. Surgery 148:1257–1126
PubMedCrossRefCaron NR, Tan YY, Ogilvie JB, Triponez F, Reiff ES, Kebebew E, Duh QY, Clark OH (2006) Selective modified radical neck dissection for papillary thyroid cancer-Is level I, II and V dissection always necessary? World J Surg 30:833–840
PubMedCrossRefChan S, Karamail K, Kolodzieczyk A, Oikinimou D, Watkinson J, Paleri A, Nixon I, Kim D (2020) Systematic review of recurrence rate after hemithyroidectomy for low-risk well-differentiated thyroid cancer. Eur Thyroid 9(2):73–84.
https://doi.org/10.1159/000504961. Epub 2020 Jan 28
CrossRefChen L, Wu YH, Lee CH, Chen HA, Loh EW, Tam KW (2018) Prophylactic central neck dissection for papillary thyroid carcinoma with clinically uninvolved central neck lymph nodes: a systematic review and meta-analysis. World J Surg 42(9):2846–2857
PubMedCrossRefChien MN, Yang PS, Lee JJ et al (2017) Recurrence-associated genes in papillary thyroid cancer: an analysis of data from The Cancer Genome Atlas. Surgery 161:1642–1650
PubMedCrossRefChisholm EJ, Kulinskaya E, Tolley NS (2009) Systematic review and metaanalysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone. Laryngoscope 119:1135–1139
PubMedCrossRefChristakis I, Dimas S, Kafetzis ID, Roukounakis N (2018) Risk stratification of 282 differentiated thyroid cancers found incidentally in 1369 total thyroidectomies according to the 2015 ATA guidelines; implications for management and treatment. Ann R Coll Surg Engl 100:357–365
PubMedPubMedCentralCrossRefChung YS, Kim JY, Bae JS et al (2009) Lateral lymph node metastasis in papillary thyroid carcinoma: Results of therapeutic lymph node dissection. Thyroid 19:241–224
PubMedCrossRefCibas ES, Ali SZ (2017) The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid 20q17:1341–1346
CrossRefCooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214
PubMedCrossRefCooper DS, Tufano RP (2012) Prophylactic central neck dissection in differentiated thyroid cancer: a procedure in search of an indication. Thyroid 4:341–343
CrossRefDong S, Xie X-J, Xia Q et al (2019) Indicators of multifocality in papillary thyroid carcinoma concurrent with Hashimoto’s thyroiditis. Am J Cancer Res 9(8):1786–1795
Dralle H, Damm I, Scheumann GFW et al (1994) Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 24:112–121
PubMedCrossRefDralle H, Lorenz K, Machens A (2009) Chirurgie der Schilddrüsenkarzinome. Chirurg 80:1069–1083
PubMedCrossRefDralle H, Musholt TJ, Schabram J, Steinmüller T, Frilling A, Simon D, Goretzki PE, Niederle B, Scheuba C, Clerici T, Hermann M, Kußmann J, Lorenz K, Nies C, Schabram P, Trupka A, Zielke A, Karges W, Luster M, Schmid KW, Vordermark D, Schmoll HJ, Mühlenberg R, Schober O, Rimmele H, Machens A, German Societies of General and Visceral Surgery; Endocrinology; Nuclear Medicine; Pathology; Radiooncology; Oncological Hematology; and the German Thyroid Cancer Patient Support Organization Ohne Schilddrüse leben e. V. (2013) German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg 398(3):347–375
Dutch Association of comprehensive cancer centres thyroid cancer (2007) National evidence-based guideline. Version 1.0.
http://www.oncoline.nl2007. Zugegriffen am 20.10.2020
Feng J, Gan X, Shen F et al (2018) The role of two foci for predicting central lymph node metastasis in papillary thyroid carcinoma: a meta-analysis. Int J Surg 52:166–170
PubMedCrossRefFilho J, Zafereo ME, Ahmad FI, Nixon IJ, Shaha AR, Vander Poorten V, Sanabria A, Hefetz AK, Robbins KT, Kamani D, Randolph GW, Coca-Pelaz E, Simo R, Rinaldo A, Angelos P, Ferlito A, Kowalski LP (2018) Decision making for the central compartment in differentiated thyroid cancer. Eur J Surg Oncol 44(11):1671–1678.
https://doi.org/10.1016/j.ejso.2018.08.005. Epub
CrossRefFritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (Hrsg) (2000) International classification of diseases for oncology, 3. Aufl. WHO, Genf 2000, ISBN 92-4-164534-8
Gilles RG, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L (2017) European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS. Eur Thyroid J 6:225–237.
https://doi.org/10.1159/000478927CrossRefGiordano D, Valcavi R, Thompson GB, Pedroni C, Renna L, Gradoni P, Barbieri V (2012) Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid 22:911–917
PubMedCrossRefGiovanella L, Piccardo A, Paone G, Foppiani L, Treglia G, Ceriani L (2013) Thyroid lobe ablation with iodine-131I in patients with differentiated thyroid carcinoma: a randomized comparison between 1.1 and 3.7 GBq activities. Nucl Med Commun 34:767–770
PubMedCrossRefHa EJ, Moon WJ, Na DG, Lee YH, Choi N, Kim SJ, Kim JK (2016) A multicenter prospective validation study for the Korean thyroid imaging reporting and data system in patients with thyroid nodules. Korean J Radiol 17(5):811–821
PubMedPubMedCentralCrossRefHartl DM, Leboulleux S, Al Ghuzlan A, Baudin E, Chami L, Schlumberger M, Martin MD, Travagli JP (2012) Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg 255:777–783
PubMedCrossRefHaslerud T, Brauckhoff K, Reisaeter L et al (2016) 18F-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysis. Acta Radio 57:1193–2000
Haugen BR, Alexander EK, Alexander KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 269:1–133
CrossRefHorvath E, Majlis S, Rossi R, Franco C, Niedmann JP, Castro A, Dominguez M (2009) An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab 90(5):1748–1751
CrossRefHu J-Q, Wen D, Ma B, Zhang TT, Liao T, Shi X, Wang YL, Zhu YX, Wang Y, Wei WJ, Ji QH (2019) The extent of lymph node yield in central neck dissection can be affected by preoperative and intraoperative assessment and alter the prognosis of papillary thyroid carcinoma. Cancer Medicine.
http://wileyonlinelibrary.com/journal/cam4. Zugegriffen am 20.10.2020
Hughes DT, Rosen JE, Evans DB et al (2018) Prophylactic central compartment neck dissection in papillary thyroid cancer and effect on locoregional recurrence. Ann Surg Oncol 25:2526–2534
PubMedCrossRefIto Y, Miyauchi A, Kudo T et al (2017a) The effectiveness of prophylactic modified neck dissection for reducing the development of lymph node recurrence of papillary thyroid carcinoma. World J Surg 41:2283–2289
PubMedPubMedCentralCrossRefIto Y, Miyauchi A (2007) Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg 31:905–915
PubMedCrossRefJi YB, Lee DW, Song CM, Kim KR, Park CW, K (2014) The accuracy of intraoperative determination of central node metastasis by the surgeon in papillary thyroid carcinoma. Otolaryngol Head Neck Surg 150:542–547
Kayser C, Tittelbach-Helmrich D, Meyer S, Thomusch O (2011) Indikation und Ausmaß der zervikalen Lymphadenektomie beim differenzierten Schilddrüsenkarzinom. Zentralbl Chir 136:364–373
PubMedCrossRefKim SK, Park I, Woo J-W, Lee JH, Kim JH, Kim JS (2017a) Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: analysis of 8,676 patients at a single institution. Surgery 161:485–492
PubMedCrossRefKim SK, Woo JW, Park I, Lee JH, Choe JH, Kim JH et al (2017b) Computed tomography-detected central lymph node metastasis in ultrasonography node-negative papillary thyroid carcinoma: is it really significant? Ann Surg Oncol 24:442–449
PubMedCrossRefKwak JY, Han KH, Yoon JH, Moon HJ, Son EU, Park SH, Jung HK, Choi JS, Kim BM, Kim EK (2011) Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology 260(3):892–899
PubMedCrossRefKwon H, Jeon MJ, Kim WG et al (2017) A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study. Eur J Endocrinol 176:371–378
PubMedCrossRefLang BH, Ng SH, Lau LL, Cowling BJ, Wong KP et al (2013) A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy. Thyroid 23:1087–1098
PubMedCrossRefLee YS, Lim YS, Lee JC et al (2010) Clinical implication of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report. World J Surg 34:2558–2563
PubMedCrossRefLim YC, Choi EC, Yoon YH et al (2010) Occult lymph node metastases in neck level V in papillary thyroid carcinoma. Surgery 147:241–245
PubMedCrossRefLiu L-S, Liang J, Li J-H et al (2017a) The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis. Eur J Otorhinolaryngol 274:1327–1338
CrossRefLiu W, Cheng R, Su Y et al (2017b) Risk factors of central lymph node metastasis of papillary thyroid carcinoma. Medicine 96:43–49
Liu Z, Wang L, Yi P et al (2014) Risk factors for central lymph node metastasis of patients with papillary thyroid microcarcinoma: a meta-analysis. Int J Exp Pathol 7(3):932–937
Liu Z, Zhao Q, Liu C et al (2018) Is biopsy enough for papillary thyroid microcarcinoma? Medicine 97:31–37
Lloyd RV, Osamura RY, Klöppel G et al (2017) WHO classification of tumors of endocrine organs, Bd 10. IARC, Lyon
Lorenz K, Abuazab M, Sekulla C et al (2010) Management of lymph fistulas in thyroid surgery. Langenbecks Arch Surg 395:911–917
PubMedCrossRefMachens A, Dralle H (2009) Prediction of mediastinal lymph node metastasis in papillary thyroid cancer. Ann Surg Oncol 16:171–176
PubMedCrossRefMachens A, Hauptmann S, Dralle H (2009) Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery 145:176–181
PubMedCrossRefMadenci AL, Caragacianu D, Boeckmann JO, Stack BC, Shin JJ (2014) Lateral neck dissection for well-differentiated thyroid carcinoma: a systematic review. Laryngoscope 124:1724–1734
PubMedCrossRefMatsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Magoshi S, Akaishi J, Masaki C, Kawano M, Suganuma N, Rino Y, Masuda M, Kameyama K, Takami H, Ito K (2014) Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. World J Surg 38:68–79
PubMedCrossRefMendelsohn AH, Elashoff DA, Abemayor E, St John MA (2010) Surgery for papillary thyroid carcinoma: is lobectomy enough? Arch Otolaryngol Head Neck Surg 136(11):1055–1061
PubMedCrossRefMitchell AL, Gandhi A, Scott-Coombes D, Perros P (2016) Management of thyroid cancer: United Kingdom national multidisciplinary guidelines. J Laryngol Otol 130(Suppl2):150–160
Miyauchi A, Kudo T, Ito Y, Oda H, Sassai H, Higashiyama T, Fukushima M, Masuoka H, Kihara M, Miya A (2017) Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance. Surgery.
https://doi.org/10.1016/j.surg.2017.03.028Musholt TJ, Musholt PB, Behrend M et al (1999) Invasive differentiated thyroid carcinoma: tracheal resection and reconstruction procedures in the hands of the endocrine surgeon. Surgery 126:1078–1087
PubMedCrossRefNixon IJ, Ganly I, Patel SG, Palmer FL, Whitcher MM, Tuttle RM, Shaha A, Shah JP (2012) Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery 151:571–579
PubMedCrossRefPacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of the patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787–803
PubMedCrossRefPassler C, Scheuba C, Asari R et al (2005) Importance of tumour size in papillary and follicular thyroid cancer. Br J Surg 92:184–189
PubMedCrossRefPereira JA, Jimeno J, Miquel J et al (2005) Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138:1095–1101
PubMedCrossRefPerros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard BG, Gilbert J, Harrison B, Johnson SJ, Giles TE, Moss L, Lewington V, Newbold K, Taylor J, Thakker RV, Watkinson J, Williams GR (2014) Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf.) 81(Suppl 1):1–122.
https://doi.org/10.1111/cen.12515CrossRefPiazza C, Del bon F, Barbieri D, Grazioli P, Paderno A, Perotti P, Lombardi D, Peretti G, Nicolai P (2016) Tracheal and crico-tracheal resection and anastomosis for malignancies involving the thyroid gland and the airway. Ann Otol Rhinol Laryngol 125(2):97–104
PubMedCrossRefQiu Y, Fei Y, Liu J et al (2019) Prevalence, risk factors and location of skip metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Cancer Manag Res 11:8721–8730
PubMedPubMedCentralCrossRefQu N, Zhang L, Ji Q-H et al (2015) Risk factors for central compartment lymph node metastasis in papillary thyroid microcarcinoma: a meta-analysis. World J Surg 39:2459–2470
PubMedCrossRefRaffaelli M, De Crea C, Sessa L, Giustacchini P, Revelli L, Bellantone C et al (2012) Prospective evaluation of total thyroidectomy versus ipsilateral versus bilateral central neck dissection in patients with clinically node-negative papillary thyroid carcinoma. Surgery 152:957–964
PubMedCrossRefRaffaelli M, de Crea C, Sessa L, Fadda G, Bellantone C, Lombardi CP (2015) Ipsilateral central neck dissection plus frozen section examination versus prophylactic bilateral central neck dissection in cN0 papillary thyroid carcinoma. Ann Surg Oncol 22:2302–2308
PubMedCrossRefRandolph GW, Daniels GH (2002) Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid. Thyroid 12:989–996
PubMedCrossRefReiners C, Hänscheid H, Luster M et al (2011) Radioiodine for remnant ablation and therapy of metastatic disease. Nat Rev Endocrinol 7:589–595
PubMedCrossRefRobbins KT, Shaha AR, Medina JE, Califano JA, Wolf GT, Ferlito A, Som PM, Day TA (2008) Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 134 36(2):127–134
Roh JL, Kim DH, Park CI (2008) Prospective identification of chyle leakage in patients undergoing lateral neck dissection for metastatic thyroid cancer. Ann Surg Oncol 15:424–429
PubMedCrossRefSadowski BM, Snyder SK, Lairmore TC (2009) Routine bilateral central lymph node clearance for papillary thyroid cancer. Surgery 146:696–705
PubMedCrossRefSancho J, Thomas W, Jay Lennard J, Paunovic I, Triponez F, Sitges-Serra A (2014) Prophylactic central neck dissection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES) Langenbecks. Arch Surg 399(2):155–163
CrossRefSantra A, Bal S, Mahargan S, Bal C (2011) Long-term outcome of lobar ablation versus completion thyroidectomy in differentiated thyroid cancer. Nucl Med Commun 32:52–58
PubMedCrossRefScherl S, Mehra S, Clain J, Reis LLD, Persky M, Turk A et al (2014) The effect of surgeon experience on the detection of metastatic lymph nodes in the central compartment and the pathologic features of clinically unapparent metastatic lymph nodes: what are we missing when we don’t perform a prophylactic dissection of central compartment lymph nodes in papillary thyroid cancer? Thyroid 24:1282–1288
PubMedCrossRefShan C-X, Zhang W, Jiang D-Z et al (2012) Routine central neck-dissection in differentiated thyroid carcinoma: a systematic review and meta-analysis. Laryngoscope 122:797–804
PubMedCrossRefShindo ML, Caruana SM, Kandil E, McCaffrey JC, Orloff LA, Porterfield JR, Shaha A, Shin J, Terris D, Randolph G (2014) Management of invasive well-differentiated thyroid cancer: An American Head and Neck Society Consensus Statement AHNS Consensus Statement. Head Neck.
https://doi.org/10.1002/Hed:1379-90Slijepcevic N, Zivaljevic V, Diklic A, Jovanovic M, Oluic B, Paunovic I (2018) Risk factors associated with intrathyroidal extension of thyroid microcarcinomas. Langenbeck’s Arch Surg 403:615–622
Song J, Sun S, Dong F, Huang T, Wu B, Zhou J (2018) Predictive value of BRAF V600E mutation for lymph node metastasis in papillary thyroid cancer: a meta-analysis. Curr Med Sci 38(5):785–797
PubMedCrossRefSugitani I, Ito Y, Miyauchi A, Imai T, Suzuki S (2019) Active surveillance versus immediate surgery: questionnaire survey on the current treatment strategy for adult patients with low-risk papillary thyroid microcarcinoma in Japan. Thyroid 29(11):1563–1571
PubMedPubMedCentralCrossRefSullivan MC, Graham PH, Alexander EK et al (2017) Prevalence of contralateral tumors in patients with follicular variant of papillary thyroid cancer. Am Coll Surg 224:1021–1027
CrossRefSun W, Zheng B, Wang Z, Dong W, Qin Y, Zhang HW (2020) Meta-analysis of risk factors for CCLNM in patients with unilateral cN0 PTC. Endocr Connect 9(5):387–395
PubMedPubMedCentralCrossRefSywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L (2006) Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140:1000–1008
PubMedCrossRefTahmasebi FC, Farmer P, Powell SZ, Aldape KD, Fuller GN, Patel S et al (2013) Brain metastases from papillary thyroid carcinomas. Virchows Arch 462(4):473–480
PubMedCrossRefTessler FN, Middleton WD, Edward GG, Hoang JK, Berland LL, Teefey SA, Cronan JJ, Beland MD, Desser TS, Frates MC, Hammers LW, Hamper UM, Langer JE, Reading CC, Scoutt LM, Stavros AT (2017) ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol 14:587–595
PubMedCrossRefTing S, Synoracki S, Bockisch A, Führer D, Schmid KW (2015) Klinische Bedeutung der Schilddrüsenzytologie. Der Pathologe 36:543–552
PubMedCrossRefTötsch M, Schmid KW (2019) Auswirkungen für die Beurteilung der Feinnadelbiopsie der Schilddrüse nach der Einführung der NIFTP. Der Onkologe 25:590–595
CrossRefTong M, Li S, Li Y et al (2019) Efficacy and safety of radiofrequency, microwave and laser ablation for treating papillary thyroid microcarcinoma: a systematic review and meta-analysis. Int J Hyperthermia 36(1):1277–1285
CrossRefTsuda K, Tsurushima H, Takano S, Tsuboi K, Matsumura A (2013) Brain metastases from papillary thyroid carcinomas. Mol Clin Oncol 1(5):817–819
PubMedPubMedCentralCrossRefTuttle RM, Ball DW, Byrd D et al (2010) Thyroid carcinoma. J Natl Compr Canc Netw 8:1228–1274
PubMedCrossRefPreventive Services Task Force US (2017) Screening for thyroid cancer. JAMA 317:1882–1887
CrossRefWilgen CP van, Dijkstra PU, van der Laan BF et al (2004) Shoulder complaints after neve sparing neck dissections. Int J Oral Maxillofac Surg 33:252–527
Venkatesh S, Paternack JD, Beninato T, Drakle FT, Kluijfhout WP, Liu C, Gosnell JE, Shen WT, Clark OH, Duh QY, Su I (2017) Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer. Surgery 161:116–126
PubMedCrossRefVuong HG, Altibi AMA, Duong UNP et al (2017a) Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma- a meta-analysis. Clin Endocrinol.
https://doi.org/10.1111/cen.13413Wada N, Masudo K, Nakayama H, Suganuma N, Matsuzu K, Horakawa S, Rino Y, Masuda M, Imada T (2008) Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age. Eur J Surg Oncol 34(2):202–207
PubMedCrossRefWang F, Yu X, Shen X, Zhu G, Huang Y, Liu R, Viola D, Elisei R, Puxeddu E, Fugazzola L, Colombo C et al (2017) The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid carcinoma. J Clin Endocrinol Metab 102(9):3241–3250
PubMedPubMedCentralCrossRefWhite ML, Gauger PG, Doherty GM (2007) Central lymph node dissection in differentiated thyroid cancer. World J Surg 31:895–904
PubMedCrossRefWittekind C (Hrsg) (2017) TNM: Klassifikation maligner Tumoren. 8. Aufl. Wiley-VCH, Weinheim, ISBN 978-3-527-34280-8
Wu ZG, Yan XQ, Su RS et al (2017) How many contralateral carcinomas in patients with unilateral papillary thyroid microcarcinoma are preoperatively misdiagnosed as benign? World J Surg 41:129–135
PubMedCrossRefXiang D, XieL XY, Li Z, Hong Y, Wang P (2015) Papillary thyroid microcarcinomas located the middle part of the middle third of the thyroid gland correlates with the presence of neck metastasis. Surgery 157(3):526–533
PubMedCrossRefXu Y, Xu L, Wang J (2018) Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution. J Surg Research 221:128–134
CrossRefYan B, Hou Y, Chen D et al (2018) Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: a meta-analysis. Int J Surg 59:90–98
PubMedCrossRefZhang H-S, Lee E-K, Jung Y-S et al (2018) Total thyroidectomy’s association with survival in papillary thyroid cancers and the high proportion of total thyroidectomy in low-risk patients: analysis of Korean nationwide data. Surgery.
https://doi.org/10.1016/j.surg.2018.08.030Zhao H, Huang T, Li H (2019) Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer. Surgery 166(1):55–60
PubMedCrossRef